Katherine Denney, Gregory Fliszar Ph.D. A federal judge temporarily blocked the Health Resources and Services Administration (HRSA) from implementing its 340B Rebate Pilot Program (Rebate Program or ...

On December 29, 2025—just three days before the 340B Rebate Model Pilot Program (the Rebate Program) was set to begin—the U.S. District Court for the District of Maine issued an order granting a ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal wall, with a federal appeals court keeping a freeze on a controversial pilot ...

PORTLAND, Maine (WMTW) - The U.S. Department of Health and Human Services is appealing after a federal judge in Maine this week ruled that the federal government cannot start making changes to a drug ...

Nevada/Vernon County Chamber opens 2026 with NRMC report on rising patient volumes, service expansions, quality gains and a proposal to form a county hospital district.

The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...

The view inside a CVS pharmacy. (Photo by Lynne Terry/Oregon Capital Chronicle) In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the ...

A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.